{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T15:29:03Z","timestamp":1780586943207,"version":"3.54.1"},"reference-count":25,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2017,1,11]],"date-time":"2017-01-11T00:00:00Z","timestamp":1484092800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"},{"start":{"date-parts":[[2017,1,11]],"date-time":"2017-01-11T00:00:00Z","timestamp":1484092800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions"}],"funder":[{"name":"M\u00e4rta and Gunnar V Philipson\u00b4s Foundation;"},{"DOI":"10.13039\/501100006313","name":"Barncancerfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006313","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Blood Cancer"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1002\/pbc.26397","type":"journal-article","created":{"date-parts":[[2017,1,11]],"date-time":"2017-01-11T08:47:59Z","timestamp":1484124479000},"page":"e26397","source":"Crossref","is-referenced-by-count":12,"title":["Antibiotic use during infectious episodes in the first 6 months of anticancer treatment-A Swedish cohort study of children aged 7-16 years"],"prefix":"10.1002","volume":"64","author":[{"given":"M.","family":"af Sandeberg","sequence":"first","affiliation":[{"name":"Department of Women's and Children's Health; Childhood Cancer Research Unit; Karolinska Institutet; Stockholm Sweden"},{"name":"Department of Pediatric Hematology and Oncology; Karolinska University Hospital; Stockholm Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Johansson","sequence":"additional","affiliation":[{"name":"Department of Medicine; Karolinska Institutet; Stockholm Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Wettergren","sequence":"additional","affiliation":[{"name":"Department of Neurobiology; Care Sciences and Society; Division of Nursing; Karolinska Institutet; Stockholm Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Bj\u00f6rk","sequence":"additional","affiliation":[{"name":"Department of Women's and Children's Health; Childhood Cancer Research Unit; Astrid Lindgren Children's Hospital; Karolinska Institutet; Stockholm Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Hertting","sequence":"additional","affiliation":[{"name":"Pediatric Infectious Disease Unit; Astrid Lindgren Children's Hospital; Stockholm Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Nilsson","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology and Oncology; Karolinska University Hospital; Stockholm Sweden"},{"name":"Department of Women's and Children's Health; Childhood Cancer Research Unit; Astrid Lindgren Children's Hospital; Karolinska Institutet; Stockholm Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,1,11]]},"reference":[{"issue":"3","key":"10.1002\/pbc.26397-BIB0001|pbc26397-cit-0002","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/QCO.0b013e328351d199","article-title":"Rationalizing the approach to children with fever in neutropenia","volume":"25","author":"Ammann","year":"2012","journal-title":"Curr Opin Infect Dis"},{"issue":"19","key":"10.1002\/pbc.26397-BIB0002|pbc26397-cit-0003","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1056\/NEJM197105132841904","article-title":"Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia","volume":"284","author":"Schimpff","year":"1971","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1002\/pbc.26397-BIB0003|pbc26397-cit-0004","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/00043426-200201000-00011","article-title":"Evaluation of risk prediction criteria for episodes of febrile neutropenia in children with cancer","volume":"24","author":"Alexander","year":"2002","journal-title":"J Pediatr Hematol Oncol"},{"issue":"12","key":"10.1002\/pbc.26397-BIB0004|pbc26397-cit-0005","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1200\/JCO.2009.25.8988","article-title":"Predicting adverse events in children with fever and chemotherapy-induced neutropenia: The prospective multicenter SPOG 2003 FN study","volume":"28","author":"Ammann","year":"2010","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1002\/pbc.26397-BIB0005|pbc26397-cit-0006","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1007\/s00520-016-3074-9","article-title":"Systematic review of reduced therapy regimens for children with low risk febrile neutropenia","volume":"24","author":"Morgan","year":"2016","journal-title":"Support Care Cancer"},{"issue":"5","key":"10.1002\/pbc.26397-BIB0006|pbc26397-cit-0007","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1200\/JCO.2000.18.5.1012","article-title":"Low-risk\" prediction rule for pediatric oncology patients presenting with fever and neutropenia","volume":"18","author":"Klaassen","year":"2000","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1002\/pbc.26397-BIB0007|pbc26397-cit-0008","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/pbc.22586","article-title":"Predicting the risk of severe bacterial infection in children with chemotherapy-induced febrile neutropenia","volume":"55","author":"Macher","year":"2010","journal-title":"Pediatr Blood Cancer"},{"issue":"7","key":"10.1002\/pbc.26397-BIB0008|pbc26397-cit-0009","doi-asserted-by":"crossref","first-page":"e114","DOI":"10.1097\/INF.0b013e318215a290","article-title":"Predicting bacteremia in children with cancer and fever in chemotherapy-induced neutropenia: Results of the prospective multicenter SPOG 2003 FN study","volume":"30","author":"Agyeman","year":"2011","journal-title":"Pediatr Infect Dis J"},{"issue":"12","key":"10.1002\/pbc.26397-BIB0009|pbc26397-cit-0010","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.3324\/haematol.2013.091025","article-title":"European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: Summary of the 2011 4th European conference on infections in leukemia","volume":"98","author":"Averbuch","year":"2013","journal-title":"Haematologica"},{"key":"10.1002\/pbc.26397-BIB0010|pbc26397-cit-0011","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1186\/1471-2334-14-286","article-title":"Association between adherence to an antimicrobial stewardship program and mortality among hospitalised cancer patients with febrile neutropaenia: A prospective cohort study","volume":"14","author":"Rosa","year":"2014","journal-title":"BMC Infect Dis"},{"issue":"4","key":"10.1002\/pbc.26397-BIB0011|pbc26397-cit-0012","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1136\/archdischild-2013-303810","article-title":"A reaudit of current febrile neutropenia practice in UK paediatric oncology centres prior to implementation of NICE guidance","volume":"98","author":"Bate","year":"2013","journal-title":"Arch Dis Child"},{"issue":"2","key":"10.1002\/pbc.26397-BIB0012|pbc26397-cit-0013","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/leu.2009.251","article-title":"Long-term results of NOPHO ALL-92 and ALL-2000 studies of childhood acute lymphoblastic leukemia","volume":"24","author":"Schmiegelow","year":"2010","journal-title":"Leukemia"},{"issue":"5","key":"10.1002\/pbc.26397-BIB0013|pbc26397-cit-0014","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/pbc.20810","article-title":"Management of febrile neutropenia in pediatric oncology patients: A Canadian survey","volume":"48","author":"Boragina","year":"2007","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"10.1002\/pbc.26397-BIB0014|pbc26397-cit-0015","first-page":"2375","article-title":"Analysis of the risk factors for febrile neutropenia in patients with bone and soft tissue sarcoma","volume":"35","author":"Aoyagi","year":"2015","journal-title":"Anticancer Res"},{"issue":"3","key":"10.1002\/pbc.26397-BIB0015|pbc26397-cit-0016","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/pbc.24231","article-title":"Length of stay and treatment-related complications are similar in pediatric and AYA patients with bone sarcoma in United States children's hospitals","volume":"60","author":"Audino","year":"2013","journal-title":"Pediatr Blood Cancer"},{"issue":"12","key":"10.1002\/pbc.26397-BIB0016|pbc26397-cit-0017","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1038\/bjc.2015.159","article-title":"Long-term adverse outcomes in survivors of childhood bone sarcoma: The British Childhood Cancer Survivor Study","volume":"112","author":"Fidler","year":"2015","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1002\/pbc.26397-BIB0017|pbc26397-cit-0018","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/apa.12077","article-title":"Age and risk factors influence the microbial aetiology of bloodstream infection in children","volume":"102","author":"Luthander","year":"2013","journal-title":"Acta Paediatr"},{"issue":"1","key":"10.1002\/pbc.26397-BIB0018|pbc26397-cit-0019","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/BF00326637","article-title":"Prospective multicentric study of the etiology of 1051 bacteremic episodes in 782 cancer patients. CEMIC (French-Belgian Study Club of Infectious Diseases in Cancer)","volume":"1","author":"Coullioud","year":"1993","journal-title":"Support Care Cancer"},{"issue":"3","key":"10.1002\/pbc.26397-BIB0019|pbc26397-cit-0020","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3109\/08880018.2013.772683","article-title":"Catheter-associated bloodstream infections in pediatric hematology-oncology patients","volume":"30","author":"Celebi","year":"2013","journal-title":"Pediatr Hematol Oncol"},{"issue":"1","key":"10.1002\/pbc.26397-BIB0020|pbc26397-cit-0021","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1155\/2014\/702621","article-title":"Mortality related to coagulase-negative staphylococcal bacteremia in febrile neutropenia: A cohort study","volume":"25","author":"Rosa","year":"2014","journal-title":"Can J Infect Dis Med Microbiol"},{"issue":"4","key":"10.1002\/pbc.26397-BIB0021|pbc26397-cit-0022","doi-asserted-by":"crossref","first-page":"e271","DOI":"10.1016\/j.ijid.2012.10.010","article-title":"Utility of PCR amplification and DNA microarray hybridization of 16S rDNA for rapid diagnosis of bacteremia associated with hematological diseases","volume":"17","author":"Negoro","year":"2013","journal-title":"Int J Infect Dis"},{"issue":"8","key":"10.1002\/pbc.26397-BIB0022|pbc26397-cit-0023","doi-asserted-by":"crossref","first-page":"e0135756","DOI":"10.1371\/journal.pone.0135756","article-title":"Bacterial landscape of bloodstream infections in neutropenic patients via high throughput sequencing","volume":"10","author":"Gyarmati","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"10.1002\/pbc.26397-BIB0023|pbc26397-cit-0024","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jiph.2012.12.005","article-title":"Antimicrobial agent prescription patterns for chemotherapy-induced febrile neutropenia in patients with hematological malignancies at Sultan Qaboos University Hospital, Oman","volume":"6","author":"Al Balushi","year":"2013","journal-title":"J Infect Public Health"},{"issue":"5","key":"10.1002\/pbc.26397-BIB0024|pbc26397-cit-0025","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1007\/s00520-012-1653-y","article-title":"Developing a national \u201clow risk\u201d febrile neutropenia framework for use in children and young people's cancer care","volume":"21","author":"Gibson","year":"2013","journal-title":"Support Care Cancer"},{"issue":"5","key":"10.1002\/pbc.26397-BIB0025|pbc26397-cit-0026","doi-asserted-by":"crossref","first-page":"e0154662","DOI":"10.1371\/journal.pone.0154662","article-title":"Antibiotic prescriptions and prophylaxis in Italian children. Is it time to change? Data from the ARPEC project","volume":"11","author":"Luca","year":"2016","journal-title":"PLoS One"}],"container-title":["Pediatric Blood & Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpbc.26397","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/pbc.26397","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,4]],"date-time":"2021-07-04T10:46:58Z","timestamp":1625395618000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pbc.26397"}},"subtitle":["SANDEBERG ET AL."],"short-title":[],"issued":{"date-parts":[[2017,1,11]]},"references-count":25,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"URL":"https:\/\/doi.org\/10.1002\/pbc.26397","archive":["Portico"],"relation":{},"ISSN":["1545-5009"],"issn-type":[{"value":"1545-5009","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1,11]]}}}